Background: With promising efficacy results from randomized control trials of human
papillomavirus (HPV) vaccines and the availability of new screening paradigms …

A critical review of cost-effectiveness analyses of HPV vaccination in males was conducted
and nine studies were identified in different countries. Due to the heterogeneity among these …

Abstract Background The World Health Organization (WHO) recommends that the cost
effectiveness of introducing human papillomavirus (HPV) vaccination is considered before …

With a human papillomavirus (HPV) vaccine soon to become available for widespread use,
several studies have modelled the cost-effectiveness of vaccination. These pioneer studies …

We describe a simplified model, based on the current economic and health effects of human
papillomavirus (HPV), to estimate the cost-effectiveness of HPV vaccination of 12-year-old …

Introduction: Human papillomavirus (HPV) is one of the world's most common sexually
transmitted infections, and has been associated with a number of cervical and non-cervical …

Background The success of human papillomavirus (HPV) national immunization program
depends on effective strategies in optimizing the uptake of HPV vaccine. Given the …

OBJECTIVE: We describe the heterogeneity of the estimates of the incremental cost per
quality-adjusted year of life (QALY) within and between cost-utility studies of the human …

Background Human papillomavirus (HPV) infection can have severe consequences both in
women and men. Preadolescent girls are vaccinated against HPV worldwide but a gender …

Introduction: Many economic evaluations of HPV vaccination have been published, but most
have focused on the prevention of cervical disease as a primary health outcome. The cost …